Enhabit, Inc.

Equities

EHAB

US29332G1022

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 10:12:57 2024-04-29 am EDT 5-day change 1st Jan Change
10.22 USD +1.94% Intraday chart for Enhabit, Inc. -0.58% -1.45%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UBS Adjusts Enhabit Price Target to $10 From $9.50, Maintains Neutral Rating MT
North American Morning Briefing : Stock Futures -2- DJ
UBS Upgrades Enhabit to Neutral From Sell, $9.50 Price Target MT
Transcript : Enhabit, Inc., 2023 Earnings Call, Mar 07, 2024
North American Morning Briefing : Powell Still in -2- DJ
Enhabit, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Earnings Flash (EHAB) ENHABIT Reports Q4 EPS $0.06, vs. Street Est of $0.03 MT
Jefferies Adjusts Price Target on Enhabit to $14 From $15, Maintains Buy Rating MT
North American Morning Briefing : Stock Futures -2- DJ
TD Cowen Starts Enhabit With Market Perform Rating MT
Transcript : Enhabit, Inc., Q3 2023 Earnings Call, Nov 08, 2023
Enhabit, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Enhabit, Inc. Enters Second Amendment to the Credit Agreement CI
Earnings Flash (EHAB) ENHABIT Reports Q3 EPS $0.03, vs. Street Est of $0.07 MT
(EHAB) ENHABIT Expects Fiscal Year 2023 EPS Range $0.09 - $0.31 MT
Enhabit, Inc. Revises Earnings Guidance for the Year 2023 CI
AREX Capital Management Issues Letter to Board of Directors of Enhabit CI
Enhabit Formally Launches Strategic Alternatives Review Process; Shares Rise After Hours MT
Enhabit Begins Exploration of Strategic Alternatives CI
Credit Suisse Adjusts Enhabit's Price Target to $12 From $15, Keeps Neutral Rating MT
Transcript : Enhabit, Inc., Q2 2023 Earnings Call, Aug 10, 2023
Enhabit, Inc. Revises earnings Guidance Its Full-Year 2023 CI
Earnings Flash (EHAB) ENHABIT Reports Q2 EPS $0.04, vs. Street Est of $0.13 MT
(EHAB) ENHABIT Forecasts Fiscal Year 2023 EPS Range $0.28 - $0.46 MT
Enhabit, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Chart Enhabit, Inc.
More charts
Enhabit, Inc. is a provider of home health and hospice services. The Company’s segments include Home Health and Hospice. The Home Health segment provides a range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. Its home health business benefits from a diversity of referral sources, with patients referred from acute care hospitals, inpatient rehabilitation facilities, surgery centers, assisted living facilities, and skilled nursing facilities, as well as community physicians. The Hospice segment provides hospice services for terminally ill patients and their families. Its Medicare-certified hospice operations provide hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and family member bereavement counseling. It operates over 110 hospice agencies and 255 home health agencies.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
10.03 USD
Average target price
10.93 USD
Spread / Average Target
+8.96%
Consensus
  1. Stock Market
  2. Equities
  3. EHAB Stock
  4. News Enhabit, Inc.
  5. Oppenheimer Initiates Coverage on Enhabit With Perform Rating